MedTrace Logo

Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study

NCT01382784 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-06-27

No results posted yet for this study

Summary

There is growing evidence that psoriasis is a systemic disorder which enhances atherosclerosis and the risk of cardiovascular disease. Epidemiological studies have shown an independent association between psoriasis and atherosclerosis, stroke and coronary artery disease. The main goal of this on-going study is to register data which will enable the identification of new markers of atherosclerosis activity and carotid plaque instability in patients with severe psoriasis.

Conditions

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01382784 on ClinicalTrials.gov